References
- Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281.
- Deputy NP, Kim SY, Conrey EJ, et al. Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth–United States, 2012–2016. Morb Mortal Wkly Rep. 2018;67(43):1201–1207.
- Classification and diagnosis of diabetes. Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31.
- Tennant PW, Glinianaia SV, Bilous RW, et al. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia. 2014;57(2):285–294.
- Yogev C, Hod , et al. Hyperglycemia and adverse pregnancy outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol. 2010;202(3):255.e1–7.
- Kitzmiller JL, Wallerstein R, Correa A, et al. Preconception care for women with diabetes and prevention of major congenital malformations. Birth Defects Res A Clin Mol Teratol. 2010;88(10):791–803.
- Stotland NE, Caughey AB, Breed EM, et al. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet. 2004;87(3):220–226.
- Weckbach LT, Muramatsu T, Walzog B. Midkine in inflammation. Scientific World J. 2011;11:2491–2505.
- Yazihan N. Midkine in inflammatory and toxic conditions. Curr Drug Deliv. 2013;10(1):54–57.
- Cai YQ, Lv Y, Mo ZC, et al. Multiple pathophysiological roles of midkine in human disease. Cytokine. 2020;135:155242.
- ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–e64.
- Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.
- Yazihan N, Erol SA, Akdas S, et al. Serum midkine level might be a diagnostic tool for COVID19 disease in pregnancy: from the disease severity, hospitalization and disease progression respects. Cytokine. 2022;149:155751.
- Aynacıoğlu A, Bilir A, Tuna MY. Involvement of midkine in autoimmune and autoinflammatory diseases. Mod Rheumatol. 2019;29(4):567–571.
- Wu GC, Yuan H, Pan HF, et al. Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus. Oncotarget. 2017;8(25):40181–40189.
- Metwalley KA, Farghaly HS, Gabri MF, et al. Midkine: utility as a predictor of early diabetic nephropathy in children with type 1 diabetes mellitus. JCRPE. 2021;13(3):293–299.
- Fan N, Sun H, Wang Y, et al. Midkine, a potential link between obesity and insulin resistance. PLoS One. 2014;9(2):e88299.
- Kapoor N, Sankaran S, Hyer S, et al. Diabetes in pregnancy: a review of current evidence. Curr Opin Obstet Gynecol. 2007;19(6):586–590.
- Nold JL, Georgieff MK. Infants of diabetic mothers. Pediatr Clin North Am. 2004;51(3):619–637.